NCT06897527 2025-07-08A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)GlaxoSmithKlinePhase 4 Not yet recruiting100 enrolled
NCT00190697 2007-05-25A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue TreatmentEli Lilly and CompanyPhase 4 Completed70 enrolled